MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2017-01-10 for ADVIA CENTAUR XP PROGESTERONE (PRGE) N/A 10310305 manufactured by Siemens Healthcare Diagnostics, Inc..
[64429796]
An mdr was not initially filed for this complaint as no injury was described. A progesterone measurement of 0. 63 ng/ml when 0 ng/ml in most instances is not considered clinically significant as both measurements are either within or below the expected reference interval depending on timing of the test. Siemens investigated cross-reactivity of dhea-s in the advia centaur xp progesterone assay, dimension vista loci progesterone assay, immulite/immulite 1000 progesterone assay and immulite 2000 progesterone assay and confirmed that dhea-s may cause elevated progesterone results in these assays. Dhea-s may be used as part of an ivf treatment plan for patients who are also being considered for fresh embryo transfer. A falsely elevated progesterone result around the clinical decision threshold of approximately 1. 0 ng/ml may lead to misinterpretation of progesterone levels and consideration of fresh embryo transfer cancellation and subsequent cryopreservation of the embryo(s). Siemens distributed urgent medical device correction cc 17-06. A. Us to customers in the united states and urgent field safety notice cc 17-06. A. Ous to customers outside the united states on january 4, 2017. These communications notify customers of the crossreactivity of dhea-s in the assays and advise customers to use an alternate method such as liquid chromatography-mass spectrometry (lc-ms) when measuring progesterone in patients using dhea-s supplements. No further investigation is required.
Patient Sequence No: 1, Text Type: N, H10
[64429797]
Customer contacted siemens requesting information regarding cross-reactivity of dhea-s with the advia centaur xp progesterone assay. The customer noted that there have been elevated progesterone results from patients who were taking dhea-s the customer reported that some doctors have taken their patients off of dhea-s. There are no reports of adverse health consequences due to the elevated advia centaur xp progesterone results.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 1219913-2016-00273 |
MDR Report Key | 6238212 |
Report Source | HEALTH PROFESSIONAL,USER FACI |
Date Received | 2017-01-10 |
Date of Report | 2017-01-10 |
Date of Event | 2015-12-21 |
Date Mfgr Received | 2015-12-21 |
Date Added to Maude | 2017-01-10 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | LOUISE MCLAUGHLIN |
Manufacturer Street | 333 CONEY STREET |
Manufacturer City | EAST WALPOLE MA 02032 |
Manufacturer Country | US |
Manufacturer Postal | 02032 |
Manufacturer Phone | 5086604381 |
Manufacturer G1 | SIEMENS HEALTHCARE DIAGNOSTICS, INC |
Manufacturer Street | 333 CONEY STREET |
Manufacturer City | EAST WALPOLE MA 02032 |
Manufacturer Country | US |
Manufacturer Postal Code | 02032 |
Single Use | 3 |
Remedial Action | RC |
Previous Use Code | 3 |
Removal Correction Number | 1219913-01/04/2017-001-C |
Event Type | 3 |
Type of Report | 3 |
Brand Name | ADVIA CENTAUR XP PROGESTERONE (PRGE) |
Generic Name | PROGESTERONE IMMUNOASSAY |
Product Code | JLS |
Date Received | 2017-01-10 |
Model Number | N/A |
Catalog Number | 10310305 |
Lot Number | 273 |
Device Expiration Date | 2016-08-28 |
Operator | PHYSICIAN |
Device Availability | N |
Device Eval'ed by Mfgr | N |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | SIEMENS HEALTHCARE DIAGNOSTICS, INC. |
Manufacturer Address | TARRYTOWN NY 10591 US 10591 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 2017-01-10 |